EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma

Kai Lei iD, Ruihao Liang iD, Binghua Tan iD, Lin Li, Yingcheng Lyu, Kexi Wang, Wenjian Wang, Kefeng Wang, Xueting Hu, Duoguang Wu, Huayue Lin iD, Minghui Wang iD

Oxidative Medicine and Cellular Longevity · 2023

DOI: 10.1155/2023/6811625 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oxidative Medicine and Cellular Longevity, 2023. Verfasst von Kai Lei und 11 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangz…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Cytochrome P-450 Enzyme System, Lung Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, Guangzhou Science and Technology Program key projects, Basic and Applied Basic Research Fund of Guangzhou Basic Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lipid metabolism reprogramming played an important role in cancer occurrence, development, and immune regulation. The aim of this study was to identify and validate lipid metabolism-related genes (LMRGs) associated with the phenotype, prognosis, and immunological characteristics of lung squamous cell carcinoma (LUSC).

Methods

In the TCGA cohort, bioinformatics and survival analysis were used to identify lipid metabolism-related differentially expressed genes (DEGs) associated with the prognosis of LUSC. PTGIS/HRASLS knockdown and overexpression effects on the LUSC phenotype were analyzed in vitro experiments. Based on the expression distribution of PTGIS/HRASLS, LUSC patients were divided into two clusters by consensus clustering. Clinical information, prognosis, immune infiltration, expression of immune checkpoints, and tumor mutation burden (TMB) level were compared between the TCGA and GSE4573 cohorts. The genes related to clustering and tumor immunity were screened by weighted gene coexpression network analysis (WGCNA), and the target module genes were analyzed by functional enrichment analysis, protein-protein interaction (PPI) analysis, and immune correlation analysis.

Results

191 lipid metabolism-related DEGs were identified, of which 5 genes were independent prognostic genes of LUSC. PTGIS/HRASLS were most closely related to LUSC prognosis and immunity. RT-qPCR, western blot (WB) analysis, and immunohistochemistry (IHC) showed that the expression of PTGIS was low in LUSC, while HRASLS was high. Functionally, PTGIS promoted LUSC proliferation, migration, and invasion, while HRASLS inhibited LUSC proliferation, migration, and invasion. The two clusters’ expression and distribution of PTGIS/HRASLS had the opposite trend. Cluster 1 was associated with lower pathological staging (pT, pN, and pTNM stages), better prognosis, stronger immune infiltration, higher expression of immune checkpoints, and higher TMB level than cluster 2. WGCNA found that 28 genes including CD4 and IL10RA were related to the expression of PTGIS/HRASLS and tumor immune infiltration. PTGIS/HRASLS in the GSE4573 cohort had the same effect on LUSC prognosis and tumor immunity as the TCGA cohort.

Conclusions

PTGIS and HRASLS can be used as new therapeutic targets for LUSC as well as biomarkers for prognosis and tumor immunity, which has positive significance for guiding the immunotherapy of LUSC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungCarcinoma, Squamous CellCytochrome P-450 Enzyme SystemLung NeoplasmsPhospholipases AHumansBiomarkers, TumorGene Expression Regulation, NeoplasticLipid MetabolismLungPhenotype

Substanzen

Biomarkers, TumorCytochrome P-450 Enzyme SystemPTGIS protein, humanPLAAT1 protein, humanPhospholipases A

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Department of Thoracic Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Department of Thoracic Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, China.
  • Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

ORCID-Profile: Kai Lei, Ruihao Liang, Binghua Tan, Huayue Lin, Minghui Wang

Förderung

  • Fundamental Research Funds for the Central Universities
  • Guangzhou Science and Technology Program key projects
  • Basic and Applied Basic Research Fund of Guangzhou Basic Research Program
  • Guangdong Basic and Applied Basic Research Foundation
  • Guangdong Science and Technology Department
  • Natural Science Foundation of Guangdong Province
  • National Natural Science Foundation of China

Zitieren

APA

Lei, K., Liang, R., Tan, B., Li, L., Lyu, Y., Wang, K., Wang, W., Wang, K., Hu, X., Wu, D., Lin, H., & Wang, M. (2023). Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma. Oxidative Medicine and Cellular Longevity. https://doi.org/10.1155/2023/6811625

Vancouver

Lei K, Liang R, Tan B, Li L, Lyu Y, Wang K, et al. Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma. Oxidative Medicine and Cellular Longevity. 2023. doi:10.1155/2023/6811625

BibTeX
@article{Lei2023,
  author = {Lei, Kai and Liang, Ruihao and Tan, Binghua and Li, Lin and Lyu, Yingcheng and Wang, Kexi and Wang, Wenjian and Wang, Kefeng and Hu, Xueting and Wu, Duoguang and Lin, Huayue and Wang, Minghui},
  title = {Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma},
  journal = {Oxidative Medicine and Cellular Longevity},
  year = {2023},
  doi = {10.1155/2023/6811625}
}
Kostenlos starten →